Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Hersch

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Neurobiology of Disease|July 13, 2001
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's diseaseO A Andreassen, A Dedeoglu, R J Ferrante, et al.
Nature Medicine|July 11, 2000
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington diseaseM Chen, V O Ona, M Li, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 21, 2008
Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implicationsD Brocklebank, J Gayán, J M Andresen, et al.
Neuron|July 13, 1999
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.
Neurology|January 26, 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGS M Hersch, S Gevorkian, K Marder, et al.
Neurology|February 11, 2012
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionJ-M Lee, E M Ramos, J-H Lee, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Neurobiology of Disease|July 13, 2001
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's diseaseO A Andreassen, A Dedeoglu, R J Ferrante, et al.
Nature Medicine|July 11, 2000
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington diseaseM Chen, V O Ona, M Li, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 21, 2008
Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implicationsD Brocklebank, J Gayán, J M Andresen, et al.
Neuron|July 13, 1999
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.
Neurology|January 26, 2006
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGS M Hersch, S Gevorkian, K Marder, et al.
Neurology|February 11, 2012
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionJ-M Lee, E M Ramos, J-H Lee, et al.
Pageof 5